Financials
- Market Capitalization 331.56 M
- Employee 389
- Founded 1999
- CEO N/A
- Website www.standardbio.com
- Headquarter Delaware, United States
- FIGI BBG000S8WQB6
- Industry Diagnóstico y pruebas
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
4.6
Relación precio/flujo de caja
5.37
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2823 | FLGT Fulgent Genetics, Inc. - Common Stock | 20.42 USD | -0.63% | -4.98% | +8.39% | -13.58% | 579.94 M USD | ||
| 2855 | MYGN Myriad Genetics, Inc. - Common Stock | 5.86 USD | +0.51% | -3.78% | +35.96% | -29.14% | 553.47 M USD | ||
| 3298 | PRE Prenetics Global Limited - Class A Ordinary Share | 18.68 USD | +4.59% | +8.42% | -13.80% | +129.20% | 315.21 M USD | ||
| 3586 | BDSX Biodesix, Inc. - Common Stock | 21.42 USD | 0.00% | -1.70% | +34.97% | +71.22% | 216.53 M USD |